ACTRN12620000911998尚未招募未知
Effect of In-Depth Immunological Risk Assessment on Genetic-Compatibility and Clinical Outcomes in Paediatric and Adolescent Patients of Parental Donor Kidney Transplants: The INCEPTION Study
niversity of Western Australia0 个研究点目标入组 550 人开始时间: 2020年9月14日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 550
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 2 Years 至 18 Years（—）
- 性别
- All
入选标准
- •Paediatric and adolescent patients with ESKD who have received a parental donor
- •kidney transplant aged less than or equal to 18 years between January 1990 and December 2020 will be recruited. Corresponding parental donors will also be recruited.
排除标准
- •1) Kidney transplant recipients aged over 18 years of age at time of transplantation.
- •2) Kidney transplant recipients of deceased donor kidneys.
- •3) Recipients (and corresponding donors) who are not contactable or alive (at time of recruitment) in Australia and New Zealand will be excluded. Please note that for other countries of United Kingdom, Belgium and Netherlands where a waiver of consent to extract data/utilise stored sera and DNA are permissible, the inclusion of recipient/donor pairs whom are not contactable or are deceased may be included.
研究者
相似试验
招募中
2 期
Preliminary study: Safety and Immunological Response following COVID-19 Vaccination in COVID-19 survivorsCOVID-19 survivorsCOVID-19 VaccinationTCTR20210720005Faculty of Medicine Siriraj Hospital180
招募中
不适用
Analysis of immune-related adverse event by immune checkpoint inhibitorpatients treated by immune checkpoint inhibitorJPRN-UMIN000031806Chiba University180
已完成
不适用
eurological immune-related adverse events in checkpoint Inhibitor therapyneurological (immune-related) adverse Events in checkpoint inhibitor therapyDRKS00019080niversitätsklinikum Essen66
进行中（未招募）
1 期
Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine when co-administered with Routine Pediatric Vaccines in Healthy Infants and Toddlers in EuropeHealthy volunteers (active immunization against invasive meningogoccal disease (IMD) caused by Meningococcal serogroups A, C, Y or W)MedDRA version: 20.0Level: PTClassification code 10027274Term: Meningococcal infectionSystem Organ Class: 10021881 - Infections and infestationsEUCTR2017-004731-36-ITSanofi Pasteur Inc.1,540
进行中（未招募）
1 期
Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine when co-administered with Routine Pediatric Vaccines in Healthy Infants and Toddlers in EuropeHealthy volunteers (active immunization against invasive meningogoccal disease (IMD) caused by Meningococcal serogroups A, C, Y or W)MedDRA version: 20.0Level: PTClassification code 10027274Term: Meningococcal infectionSystem Organ Class: 10021881 - Infections and infestationsEUCTR2017-004731-36-FISanofi Pasteur Inc.1,652